Categories: Business

ELEV Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Elevation Oncology, Inc. Is Fair to Shareholders

NEW YORK–(BUSINESS WIRE)–Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Elevation Oncology, Inc. (NASDAQ: ELEV) to Concentra Biosciences, LLC is fair to Elevation shareholders. Under the terms of the proposed transaction, Elevation shareholders will receive $0.36 in cash per share, plus one non-tradeable contingent value right representing the right to receive: (i) 100% of the closing net cash in excess of $26.4 million; and (ii) 80% of any net proceeds received within five years following closing from any disposition of EO-1022 that occurs within one year following closing.

- Advertisement -


- Advertisement -

Halper Sadeh encourages Elevation shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.

The investigation concerns whether Elevation and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Elevation shareholders; (2) determine whether Concentra is underpaying for Elevation; and (3) disclose all material information necessary for Elevation shareholders to adequately assess and value the merger consideration.

- Advertisement -

On behalf of Elevation shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

- Advertisement -

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

- Advertisement -

Contacts

- Advertisement -

Halper Sadeh LLC

One World Trade Center

85th Floor

New York, NY 10007

Daniel Sadeh, Esq.

Zachary Halper, Esq.

(212) 763-0060

sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

Business Wire

Recent Posts

Rodic Consultants Announces ‘Rodic Advisory & Technology’ to Power Data-Driven Governance

Rodic Consultants, a leading engineering and digital infrastructure consulting company, today announced Rodic Advisory &…

2 hours ago

Tilak Marbles Leverages 30 Years of Legacy to Meet Rising Global Demand

As the global design community gravitates toward sustainable, natural, and heritage-rich materials, Indian marble is…

2 hours ago

Nexus App Launches in Dallas Connecting Young Professionals With Top Events, Deals & Social Spots

DALLAS, TX, July 24, 2025 (GLOBE NEWSWIRE) -- A fresh way to explore Dallas is…

2 hours ago

Dassault Systmes: Q2 well aligned with objectives; Reaffirming 2025 growth outlook Advancing AI for software-defined industries

Press Release VELIZY-VILLACOUBLAY, France — July 24, 2025 Dassault Systèmes: Q2 well aligned with objectives;…

2 hours ago

Citryll Announces Formation of Scientific Advisory Board

July 24, 2025 02:00 ET  | Source: Citryll CITRYLL ANNOUNCES FORMATION OF SCIENTIFIC ADVISORY BOARD…

2 hours ago

AB Science has received approval from several European countries to initiate the confirmatory phase 3 study of masitinib in ALS

PRESS RELEASE AB SCIENCE HAS RECEIVED APPROVAL FROM SEVERAL EUROPEAN COUNTRIES TO INITIATE THE CONFIRMATORY…

2 hours ago